Thomas Quaschning Selected Research

Vasopeptidase Inhibitors

1/2006	Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
1/2005	Vasopeptidase inhibition for blood pressure control: emerging experience.
5/2003	Vasopeptidase inhibition: a new treatment approach for endothelial dysfunction.
2/2002	Vasopeptidase inhibition: effective blood pressure control for vascular protection.
11/2001	Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Quaschning Research Topics

Disease

8	Hypertension (High Blood Pressure) 03/2007 - 01/2001
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2007 - 02/2003
2	Myocardial Infarction 04/2007 - 02/2005
2	Atherosclerotic Plaque (Atheroma) 04/2007 - 06/2003
2	Cardiomegaly (Heart Hypertrophy) 11/2006 - 02/2005
2	Hypertrophy 02/2005 - 11/2001
2	Heart Failure 01/2005 - 05/2003
1	Coronary Disease (Coronary Heart Disease) 01/2008
1	Atherosclerosis 12/2007
1	Mesenteric Ischemia 04/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2007
1	Stroke (Strokes) 04/2007
1	Corneal Opacity 01/2007
1	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2007
1	Anemia 01/2007
1	Renal Insufficiency (Renal Failure) 01/2007
1	Inflammation (Inflammations) 11/2006
1	Fibrosis (Cirrhosis) 11/2006
1	Heart Diseases (Heart Disease) 11/2006
1	Renovascular Hypertension (Goldblatt Syndrome) 01/2006
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2005
1	Ventricular Remodeling 02/2005
1	Angioedema 05/2003
1	Polycythemia (Erythrocytosis) 02/2003

Drug/Important Bio-Agent (IBA)

5	Vasopeptidase InhibitorsIBA 01/2006 - 11/2001
4	SaltsIBA 11/2006 - 01/2001
3	Endothelins (Endothelin)IBA 03/2007 - 02/2003
3	Neprilysin (Neutral Endopeptidase)IBA 01/2006 - 01/2001
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2006 - 02/2002
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2006 - 01/2001
2	C-Reactive ProteinIBA 01/2008 - 12/2007
2	Endothelin-1 (Endothelin 1)IBA 03/2007 - 11/2001
2	omapatrilatIBA 11/2001 - 01/2001
1	Troponin T (Troponin T1)IBA 01/2008
1	Peroxynitrous Acid (Peroxynitrite)IBA 12/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2007
1	Proteins (Proteins, Gene)FDA Link 04/2007
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2007
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2007
1	AldosteroneIBA 11/2006
1	Progestins (Progestagens)IBA 11/2006
1	Progesterone FDA LinkGeneric 11/2006
1	OsteopontinIBA 11/2006
1	Estrogens (Estrogen)FDA Link 11/2006
1	drospirenone FDA LinkGeneric 11/2006
1	AndrogensIBA 11/2006
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 11/2006
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 11/2006
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2006
1	GlucocorticoidsIBA 11/2006
1	Ramipril (Altace)FDA LinkGeneric 01/2006
1	ReninIBA 01/2006
1	AVE 7688IBA 01/2006
1	IsoenzymesIBA 02/2005
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2005
1	EnzymesIBA 01/2005
1	Angiotensin IIIBA 06/2003
1	oxidized low density lipoproteinIBA 06/2003
1	Erythropoietin FDA Link 02/2003
1	Captopril (Capoten)FDA LinkGeneric 11/2001
1	Natriuretic PeptidesIBA 01/2001

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 04/2007 - 01/2007
1	Ligation 02/2005
1	Therapeutics 11/2001